Key result
A higher Triglyceride glucose (TyG) index was associated with an increased risk of 30-day all-cause mortality in patients with acute myocardial infarction following percutaneous coronary intervention.
Why the study?
The connection between the triglyceride glucose (TyG) index and prognosis in acute myocardial infarction (AMI) patients after percutaneous coronary intervention (PCI) remains uncertain.
Does a higher triglyceride glucose (TyG) index predict increased all-cause mortality in adult patients with acute myocardial infarction following percutaneous coronary intervention?
Cohort (n=1,410)
No
Does a higher triglyceride glucose (TyG) index predict increased all-cause mortality in adult patients with acute myocardial infarction following percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
An elevated triglyceride glucose (TyG) index is an independent predictor of 30-day and 12-month all-cause mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
The Triglyceride glucose (TyG) index is a dependable indicator of IR, with numerous studies underscoring its influence on Cardiovascular disease. Nevertheless, the connection between the TyG index and prognosis in AMI patients after PCI is still uncertain. This investigation aims to explore the link in individuals who have received PCI for AMI. Upon admission, data regarding the patients' age, sex, concurrent diseases, TyG index, and laboratory findings were meticulously documented. To discern the link between the TyG index and the 30-day and 12-month ACM, we employed a multivariate Cox proportional hazard regression model and K-M survival curve. The concordance evaluation was also enhanced by subgroup analysis. The investigation encompassed data from 1410 AMI patients who received PCI. The 30-day ACM rate was observed to be 15.1% (214/1410), while the rate at 12 months escalated to 26.0% (368/1410). Upon adjusting for potential confounders, multivariate analysis delineated a dramatic link between high TyG index and heightened mortality risk at both 30 days (HR 1.233, 95% CI 1.086-1.399) and 12 months (HR 1.127, 95% CI 0.963-1.318). According to K-M survival curve, patients presenting with higher TyG indexes demonstrated a noticeably higher probability of ACM within both the 30-day and 12-month. In AMI patients after PCI, the TyG index demonstrates a substantial link with ACM at 30-day and 12-month marks. This finding suggests the effectiveness of the TyG index in detecting AMI patients who are at a higher risk of mortality after undergoing PCI.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) conducted a cohort in Acute myocardial infarction following percutaneous coronary intervention (n=1,410). Triglyceride glucose (TyG) index vs. Lower TyG index was evaluated on 30-day all-cause mortality (HR 1.233, 95% CI 1.086-1.399, p=0.001). A higher Triglyceride glucose (TyG) index was associated with an increased risk of 30-day all-cause mortality in patients with acute myocardial infarction following percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: